Cerebrospinal fluid levels of amyloid beta 1-43 in patients with amnestic mild cognitive impairment or early Alzheimer’s disease: a 2-year follow-up study by Camilla eLauridsen, Sigrid Botne Sando, Sigrid Botne Sando, Adiba eShabnam, Ina eMøller, Guro eBerge, Gøril Rolfseng Grøntvedt, Gøril Rolfseng Grøntvedt, Inger Johanne Bakken, Øyvind eSalvesen, Geir eBråthen, Geir eBråthen, Linda Rosemary White, Linda Rosemary White

Get full text